New search | Conferencedetail
mail
Print view
 
 

7th Neuropsychiatric Drug Development Summit

Evvnt Promotion / evvnt
-
24.09.2024 - 26.09.2024  Hilton Boston Back Bay, 40 Dalton Street, 02115 Boston, Massachusetts, USA
Time: 8:00 AM - 5:00 PM
 
Conference themes
With Karuna's schizophrenia program coined as the most anticipated drug launch of 2024, and 2023 bringing brand new regulatory guidance, surging investment has reinvigorated the space with new targets, mechanisms, and technologies to transform the mental health treatment landscape.
Professional congress organizer (PCO)
Hanson Wade Group
Notes
URL:
Brochure: https://go.evvnt.com/2433814-3?pid=4832

Speakers: Aaron Koenig, Chief Medical Officer, Delix Therapeutics, Ariana Mullin, Director, Regulatory Affairs, Bristol Myers Squibb, and more
 

Enquiries and Registration:

https://go.evvnt.com/2433814-2?pid=4832
Ms. Erin Thomas
 
Categories
General Medicine
Languages
English
Congress fees
Drug Developer Pricing - Conference + Workshop Day: USD 3597.00, Drug Developer Pricing - Conference Only: USD 2599.00, Solution Provider Pricing - Conference + Workshop Day: USD 5197.00, Solution Provider Pricing - Conference Only: USD 3699.00
Organizer contact info
83 Great Titchfield Street
W1W 6RH London
United Kingdom
 
"Going International promotes access to education and training for all regardless of social, geographic and national borders."

Ärzte der WeltSwiss Tropical and Public Health InstituteOÖ Gebietskrankenkasse, Referat für Wissenschaftskooperation Centro per la Formazione Permanente e l'Aggiornamento del Personale del Servizio SanitarioÖsterreichisches Rotes KreuzÖsterreichische Gesellschaft für Public HealthAnästhesie in Entwicklungsländern e. V.Hilfswerk Austria